Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Abstract
Authors
A. Lee D. Granados E. Hulbert L. McGarry J. Fleischmann